author-photo

Feng Ye

Fujian Medical University

6

Papers

62

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Abstract CT041: ORIENT-3: A randomized, open-label, phase 3 study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small-cell lung cancer (sqNSCLC)

2021 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
Decoding the Evolutionary Response to Ensartinib in ALK-Positive Non-Small-Cell Lung Cancer Patients by Dynamic Circulating Tumor DNA Sequencing.

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Combination cyclin-dependent kinase 4/6 inhibitors and endocrine therapy versus endocrine monotherapy for hormonal receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A systematic review and meta-analysis.

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (9)
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial.

2019 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (44)